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INTRODUCTION:  Dermatoﬁbrosarcoma  protuberans  (DFSP)  is  a rare,  malignant,  soft tissue  neoplasm  of the
dermis.  Tumor  recurrence  is  common  following  resection,  and can be locally  devastating  if not  identiﬁed
in  a timely  manner.
We  report  a unique  case  of  this  rare  tumor.  This  case  poses  the  question  of  an  association  between
basal  cell  carcinoma  (BCC)  and DFSP,  and  presents  the possible  need  for increased  awareness  of  DFSP
for  healthcare  providers  and patients  with a  history  of non-melanoma  skin  cancers  as well  as  surgical  or
burn  scars.
PRESENTATION  OF  CASE:  A 77-year-old  male  with  a history  of  surgical  excision  of BCC  presented  with
several  palpable  lesions  in  the superﬁcial  cutaneous  tissue  of the right  anterior  abdominal  wall.  Most  of
the lesions  were  consistent  with  lipoma;  however,  one  lesion  near  the excision  site  of the BCC  was  more
solid  in  consistency.  The mass  was removed  with  wide  local  excision  encompassing  all  layers  down  to
the  abdominal  fascia.  Subsequent  pathology  ﬁndings  included  CD34  positive  spindle  cells  in a whorled
pattern  consistent  with  DFSP.  Resection  margins  were  positive  and  a wide  re-excision  was  performed
with  margins  being  negative.
DISCUSSION:  DFSP  comprises  approximately  0.01%  of  all  malignant  tumors.  There  are  no known  precipi-
tating  factors  of  DFSP,  but  its  presence  in surgical  and  burn  scars  is  not  uncommon.
An  association  between  DFSP  and  basal  cell  carcinoma  has  been  suggested  in  the literature.  Der-
matoﬁbroma  and rarely  DFSP  may  demonstrate  basaloid  proliferation  of  the  overlying  epidermis  with
characteristics  of BCC.  One case  reporting  coexistent  DFSP  and  BCC  located  to the  ear  also  suggested
an  association,  but concluded  that  the ﬁnding  was likely  incidental  due  to  sun  exposure.  In  our case,
the  lesion’s  location  is  less  routinely  subjected  to sun  exposure  and  points  more  towards  a possible
association.
The mainstay  of  treatment  for local  DFSP  is  wide  local  excision.  Negative  margins  with  the  removal
of  fascia  and  muscle  tissue  as necessary  is  essential  and  the  most  signiﬁcant  prognostic  factor.  Three-
dimensional  reconstructions  of DFSP  have  shown  villous  ﬁnger  like  projections  of  primary  tumors,  which
is believed  to be responsible  for local  recurrence.  Recurrence  can  be  devastating,  as  several  cases  have
demonstrated  rapid growth  of  remaining  cells  with  increased  morbidity  following  further  resection.
CONCLUSION:  Based  on this  case  and  those  found  in  the literature,  we  believe  an  association  may  exist
between  DFSP  and  BCC  and  further  study  of  this  association  is  needed.  DFSP  is a  rare  malignancy  unknown
to many  healthcare  providers,  but in the  presence  of  increased  awareness  and  physician  vigilance  in
surgical  resection  and  follow  up,  the  potential  morbidity  of  DFSP  may  be prevented.
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. IntroductionWe  report a unique case of a rare tumor, dermatoﬁbrosarcoma
rotuberans (DFSP) at the site of previous basal cell carcinoma
Abbreviations: DFSP, Dermatoﬁbrosarcoma protuberans; BC, CBasal cell carci-
oma.
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(BCC) excision. The patient presented to clinic out of concern for
several palpable lesions on the right anterior abdominal wall. All
but one lesion was consistent with lipoma, which was  removed by
wide local excision. Pathology returned with immunohistochem-
istry positivity for CD34, which is consistent with DFSP. One other
case in the literature suggests an association between the two neo-
plasms. This case presents the need for increased awareness of
DFSP and its management as well as the possible association with
non-melanoma skin cancers and surgical or burn scars.
DFSP is a rare, malignant, soft tissue neoplasm of the dermis.
The clinical presentation of this tumor ranges from a single painless
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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oFig. 1. Gr
apule to an ulcerated nodule or plaque. Local recurrence of DFSP
s common following primary resection, and can be locally devas-
ating if not identiﬁed in a timely manner. We  report a unique case
f this tumor which suggests an association with BCC and presents
he possible need for increased awareness of DFSP for healthcare
roviders and patients with a history of non-melanoma skin can-
ers, as well as surgical or burn scars.
. Presentation of case
A 77-year-old male with a history of surgical excision of BCC
even years ago presented to the clinic out of concern for sev-
ral palpable lesions in the superﬁcial cutaneous tissue of the right
nterior abdominal wall. Most of the lesions were consistent with
ipoma; however, one lesion near the excision site of the BCC was
ore solid in consistency. The mass was removed with wide local
xcision encompassing all layers down to the abdominal fascia
Fig. 1). Subsequent pathology ﬁndings included immunohisto-
hemistry positivity for CD34 (Fig. 2) and positive spindle cells in a
horled/storiform pattern consistent with DFSP (Fig. 3). Resection
argins were positive and a wide re-excision was  performed with
argins being negative. The patient is currently being monitored
s an outpatient without evidence of local recurrence.
. Discussion
DFSP comprises approximately 0.01% of all malignant tumors,
nd has an annual incidence of 4.2 per million population [1,2]. Epi-
emiological studies have shown no genetic predisposition, almost
qual sexual distribution, and no racial predilection. This tumor is
een most commonly in adults aged 20–50, but may present in
ndividuals of all ages [3].
DFSP is often mistaken for lipoma, morphea, hypertrophic scars,
ermatoﬁbroma, and insect bites. The tumors may  present as a
ingle painless papule, non-indurated patch on the skin, or as an
rea of cutaneous thickening with red or bluish discoloration at the
eriphery. The lesion may  enlarge into a lumpy nodule, ulcerate,
emorrhage, or possibly evolve into an atrophic/sclerotic plaque.
It has been well demonstrated in the literature that the ﬁnding
f DFSP in surgical and burn scars is a relatively common clinicalFig. 2. Immunohistochemistry, CD34.
presentation [4]. DFSP is routinely located to the trunk, with less
common locations of the head and neck [5]. Metastasis is rare, with
a rate of 4–6%, and if present, is most commonly to the lungs [6].
Due to the slow glowing nature of DFSP, diagnosis is often delayed
up to several years.
Histologically, the tumor cells have partial features of ﬁbrob-
lastic, histiocytic, and neuroectodermal cells, which suggests
undifferentiated mesenchymal cells as a possible origin. DFSP is
considered to be of low-grade malignancy and identiﬁed by a pat-
tern of monomorphous spindle cells with a storiform or whorled
pattern [7]. Positive immunohistochemistry for CD34 expression
is consistently seen in DFSP and is often useful in differenti-
ating DFSP from benign dermatoﬁbroma and other soft tissue
neoplasms [8].
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Fig. 3. H&E stain of spindle cells in storiform pattern.
Table 1
Timeline.
October, 2015 Patient presented to clinic
November, 2015 Lesion was removed with positive margins
November, 2015 Margins further resected with negative
margins
December, 2015 Follow up appointment in clinic with no signs
of recurrence.
March, 2016 Follow up appointment in clinic with no signs
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[3] D. Monnier, C. Vidal, L. Martin, A. Danzon, F. Pelletier, E. Puzenat, M.P. Algros,
D.  Blanc, R. Laurent, P.H. Humbert, et al., Dermatoﬁbrosarcoma protuberans: aof recurrence.
The mainstay of treatment for local DFSP is wide local excision.
egative margins with the removal of fascia and muscle tissue as
ecessary is essential and the most signiﬁcant prognostic factor
f patients with DFSP. The local recurrence rate is just below 10%
fter extensive excision and around 50% when tumor margins are
ess than 3 cm5. Three-dimensional reconstructions of DFSP have
hown villous ﬁnger like projections of primary tumors, which is
elieved to be responsible for local recurrence. Recurrence can be
evastating, as several cases have demonstrated rapid growth of
emaining cells with the increased morbidity of invasion into cuta-
eous and subcutaneous tissues following further resection [5,9].
In the literature, an association between DFSP and basal cell car-
inoma has been previously reported in one case. The authors of
he case reported coexistent DFSP and BCC located to the ear. In
his case, the ﬁnding was concluded to be more likely incidental,
ather than causative, based on the location of the tumors on an
rea commonly subjected to sun-exposure [10]. However, in our
ase, the lesion was located on the anterior abdominal wall, an area
ess commonly subjected to sun-exposure. This aspect of the case
oints more towards an association between the two neoplasms
han the previous report (Table 1).
The pathophysiology of an association may  be explained by the
ontroversial ﬁnding that benign dermatoﬁbroma and rarely DFSP,
ay  demonstrate basaloid proliferation of the overlying epidermis
ith characteristics of BCC. This association has been hypothesized
o be due to either induction of the overlying basaloid cells by the
eoplasm or possibly reactive hyperplasia due to the compression
f the cells through mass effect [10,11].PEN  ACCESS
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4. Conclusion
An association between BCC and DFSP has been suggested previ-
ously in the literature, with only one other case reported. Based on
this case, we  support that an association may  in fact exist and fur-
ther study of this association is needed. DFSP is a rare malignancy
unknown to many patients and healthcare providers. This tumors
rarity, appearance that likens more common soft tissue and der-
matologic conditions, and its capacity for devastating recurrence,
places patients at risk. We  believe this case presents the need for
increased awareness of DFSP for healthcare providers and patients
with a history of non-melanoma skin cancers as well as surgical or
burn scars. With increased provider vigilance in patient identiﬁca-
tion, surgical excision with negative margins, and close follow-up,
the potential morbidity with recurrence of this tumor can be suc-
cessfully prevented.
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